What does this number include?

FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.

Why does it only update twice a month?

US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.

Is this KERX's short float?

No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.

What is KERX's days to cover?

9.41 days for settlement date 30 Nov 2018: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.

Which funds are short?

US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.

How shorted was KERYX BIOPHARMACEUTICALS INC? KERX

KERYX BIOPHARMACEUTICALS INC left the US market in 2018. This page is a frozen archive of its reported short interest, ending 30 Nov 2018. The ticker KERX no longer refers to this company and may since have been reassigned.

15.54%

of shares outstanding reported short · settlement date 30 Nov 2018

vs previous report: −0.21
5 reports (~10 weeks): +1.34
days to cover: 9.41

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filed	Settlement before	Settlement after	Change
8 Nov 2018	16.19% 31 Oct 2018	15.75% 15 Nov 2018	−0.44
8 Aug 2018	15.58% 31 Jul 2018	15.10% 15 Aug 2018	−0.48
10 May 2018	15.35% 30 Apr 2018	14.84% 15 May 2018	−0.51
30 Apr 2018	17.01% 13 Apr 2018	14.84% 15 May 2018	−2.17
7 Feb 2018	18.65% 31 Jan 2018	17.82% 15 Feb 2018	−0.83

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

<iframe src="https://howshorted.com/embed/us/kerx-2020/" width="100%" height="430" style="border:0" loading="lazy" title="KERYX BIOPHARMACEUTICALS INC short interest chart"></iframe>
<p>Source: FINRA data compiled by <a href="https://howshorted.com/us/company/kerx-2020/">howshorted.com</a></p>

Share on X Reddit LinkedIn

Cite this page

Plain

Short position data for KERYX BIOPHARMACEUTICALS INC: FINRA, compiled by howshorted.com, settlement date 30 Nov 2018. https://howshorted.com/us/company/kerx-2020/

Wikipedia

<ref>{{cite web |title=KERYX BIOPHARMACEUTICALS INC short position data |url=https://howshorted.com/us/company/kerx-2020/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2018-11-30 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-keryx-biopharmaceuticals-inc-2018-11-30,
  title        = {KERYX BIOPHARMACEUTICALS INC short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/kerx-2020/}},
  note         = {Data: FINRA, settlement date 30 Nov 2018; accessed 2026-10-13},
  year         = {2018}
}

Sector: Healthcare

History

Full reported short interest history
Settlement date	Short %	Change
30 Nov 2018	15.54%	−0.21
15 Nov 2018	15.75%	−0.44
31 Oct 2018	16.19%	+2.84
15 Oct 2018	13.35%	−0.03
28 Sep 2018	13.38%	−0.82
14 Sep 2018	14.20%	−0.19
31 Aug 2018	14.39%	−0.71
15 Aug 2018	15.10%	−0.48
31 Jul 2018	15.58%	+0.22
13 Jul 2018	15.36%	−0.28
29 Jun 2018	15.64%	−0.80
15 Jun 2018	16.44%	+1.19
31 May 2018	15.25%	+0.41
15 May 2018	14.84%	−0.51
30 Apr 2018	15.35%	−1.66
13 Apr 2018	17.01%	−1.08
29 Mar 2018	18.09%	+0.75
15 Mar 2018	17.34%	+1.02
28 Feb 2018	16.32%	−1.50
15 Feb 2018	17.82%	−0.83
31 Jan 2018	18.65%	−0.61
12 Jan 2018	19.26%	+0.12
29 Dec 2017	19.14%	–

Newest first. Scroll inside the table for earlier dates, back to 29 Dec 2017.

Frequently asked questions

How shorted was KERYX BIOPHARMACEUTICALS INC?: KERYX BIOPHARMACEUTICALS INC left the US market in 2018. Its final reported figure was 15.54% of shares outstanding for settlement date 30 Nov 2018, per FINRA's consolidated short interest report; this page preserves its full history.
What does this number include?: FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?: US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this KERX's short float?: No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is KERX's days to cover?: 9.41 days for settlement date 30 Nov 2018: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?: US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.